Evaxion Biotech Total Debt vs. EBITDA
| EVAX Stock | USD 2.53 0.13 4.89% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.8 | 0.9 |
|
|
For Evaxion Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Evaxion Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Evaxion Biotech AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Evaxion Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Evaxion Biotech AS over time as well as its relative position and ranking within its peers.
Evaxion |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evaxion Biotech. If investors know Evaxion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evaxion Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Evaxion Biotech AS is measured differently than its book value, which is the value of Evaxion that is recorded on the company's balance sheet. Investors also form their own opinion of Evaxion Biotech's value that differs from its market value or its book value, called intrinsic value, which is Evaxion Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evaxion Biotech's market value can be influenced by many factors that don't directly affect Evaxion Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evaxion Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evaxion Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evaxion Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evaxion Biotech AS EBITDA vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Evaxion Biotech's current stock value. Our valuation model uses many indicators to compare Evaxion Biotech value to that of its competitors to determine the firm's financial worth. Evaxion Biotech AS is rated below average in total debt category among its peers. It is rated below average in ebitda category among its peers . Evaxion Biotech reported EBITDA of (19.26 Million) in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evaxion Biotech's earnings, one of the primary drivers of an investment's value.Evaxion Total Debt vs. Competition
Evaxion Biotech AS is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 327.41 Million. Evaxion Biotech holds roughly 10.87 Million in total debt claiming about 3% of equities under Health Care industry.
Evaxion EBITDA vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Evaxion Biotech |
| = | 10.87 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Evaxion Biotech |
| = | (21.4 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Evaxion EBITDA Comparison
Evaxion Biotech is currently under evaluation in ebitda category among its peers.
Evaxion Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Evaxion Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Evaxion Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Evaxion Biotech's change in net profit over the period of time. It can combine multiple indicators of Evaxion Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.3 M | -4.1 M | |
| Net Interest Income | -2.7 M | -2.6 M | |
| Interest Income | 2.7 M | 1.4 M | |
| Operating Income | -20 M | -21 M | |
| Net Loss | -22 M | -23.1 M | |
| Income Before Tax | -20.6 M | -21.7 M | |
| Total Other Income Expense Net | -825.7 K | -784.4 K | |
| Net Loss | -22.1 M | -23.2 M | |
| Net Loss | -19.9 M | -20.9 M | |
| Income Tax Expense | -909.9 K | -955.4 K | |
| Change To Netincome | 916.2 K | 870.4 K | |
| Net Loss | (1.86) | (1.95) | |
| Income Quality | 0.72 | 0.62 | |
| Net Income Per E B T | 0.87 | 0.75 |
Evaxion Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Evaxion Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Evaxion Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Evaxion Biotech's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Evaxion Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Use Investing Themes to Complement your Evaxion Biotech position
In addition to having Evaxion Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.